Cassling

AUGUST 25, 2023

Bradfield joins a leadership team dedicated to strengthening community healthcare across the country and touching 350 million patient lives by the end of the decade. Omaha, Neb. (August 25, 2023) — Cassling, an imaging and therapeutic technology, services and solutions vendor, welcomes Brian Bradfield as Chief Operating Officer. As COO of Cassling, Brian Bradfield will be responsible for ensuring the organization’s service, operations and strategy are in constant alignment with customers’ needs

Technology 98

Technology Blog 98

Science Daily - Stroke

AUGUST 25, 2023

Middle-aged adults with three or more unhealthy traits including slightly high waist circumference, blood pressure, cholesterol and glucose have heart attacks and strokes two years earlier than their peers, according to new research.

Heart Attack 67

Heart Attack Heart attacks Blood Pressure Stroke 67

Open Heart

AUGUST 25, 2023

Background Consensus guidelines support the use of implanted cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death in patients with either non-ischaemic or ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF) ≤35%. However, evidence from trials for efficacy specifically for patients with LVEF near 35% is weak.

Defibrillator 52

Defibrillator Sudden Cardiac Death Myocardial Infarction Echocardiogram 52

Science Daily - Stroke

AUGUST 25, 2023

Patients living with one of the UK's most common heart rhythm conditions are 50% less likely to die from a heart attack or stroke than they were at the start of the millennium, analysis of 70,000 newly diagnosed AF patients' health records has shown.

Heart Attack 40

Heart Attack Heart attacks Heart Rhythm Stroke 40

HeartRhythm

AUGUST 25, 2023

Among patients with ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM), myocardial fibrosis is associated with an increased risk for ventricular arrhythmia (VA). Growing evidence suggests that myocardial fat contributes to ventricular arrhythmogenesis. However, little is known about the volume and distribution of epicardial adipose tissue and intramyocardial fat and their relationship with VAs.

Arrhythmia 40

Arrhythmia Cardiomyopathy 40

Circulation

AUGUST 25, 2023

Circulation, Ahead of Print. Background:Lipoprotein(a) is a risk factor for cardiovascular events and modifies the benefit of pcsk9 inhibitors (pcsk9i). Lipoprotein(a) concentration can be measured with immunoassays reporting mass or molar concentration or a reference measurement system employing mass spectrometry. Whether the relationships between lipoprotein(a) concentrations and cardiovascular events in a high-risk cohort differ across lipoprotein(a) methods is unknown.

Risk Factors 40

Risk Factors Circulation Outcomes 40